ARTICLE | Company News
Bayhill autoimmune, endocrine news
March 7, 2011 8:00 AM UTC
Bayhill retained P2 Partners LLC to explore strategic alternatives, including a sale of company assets, partnering, or a merger or sale of the company. According to the biotech, while it has sufficien...